Catalogo dei prodotti della ricerca

AMADORI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.397
EU - Europa 447
AS - Asia 241
SA - Sud America 12
AF - Africa 4
Totale 2.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.381
IT - Italia 155
IN - India 118
SE - Svezia 117
CN - Cina 86
FI - Finlandia 42
DE - Germania 37
SG - Singapore 33
UA - Ucraina 27
BG - Bulgaria 16
CA - Canada 16
RO - Romania 15
AR - Argentina 11
BE - Belgio 10
IE - Irlanda 10
FR - Francia 8
GB - Regno Unito 6
TG - Togo 3
KR - Corea 2
AT - Austria 1
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
HU - Ungheria 1
NL - Olanda 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.101
Salva come PNG Salva come JPEG
Città #
Fairfield 210
Chandler 123
Princeton 89
Woodbridge 89
Ashburn 78
Seattle 73
Cambridge 69
Wilmington 69
Houston 65
Plano 51
Beijing 49
Ann Arbor 42
Des Moines 33
Florence 31
Millbury 29
Bremen 23
Dearborn 22
Andover 17
Boston 16
Sofia 16
San Paolo di Civitate 15
Lawrence 14
San Diego 14
Norwalk 13
Federal 11
Singapore 11
Brussels 10
Dublin 10
Rome 10
Kunming 9
Toronto 9
Falls Church 6
Hefei 6
Jacksonville 6
Ottawa 6
San Mateo 6
Naples 5
Bühl 4
Trento 4
Buffalo 3
Fuzhou 3
Lomé 3
Shenyang 3
Bisceglie 2
Bologna 2
Cagliari 2
Castellarano 2
Chengdu 2
Hyderabad 2
Jinan 2
Lecco 2
Milan 2
Nanchang 2
Nanjing 2
Napoli 2
New York 2
Redmond 2
Reggio Nell'emilia 2
Belpasso 1
Belvedere Marittimo 1
Berlin 1
Boardman 1
Budapest 1
Calvisano 1
Capena 1
Catania 1
Clearwater 1
Cologna Veneta 1
Curinga 1
Edinburgh 1
Falkenstein 1
Genova 1
Guangzhou 1
Hebei 1
Indiana 1
Istanbul 1
Malfa 1
Massa Fiscaglia 1
Medicina 1
Montreal 1
Muizenberg 1
Nanning 1
Noisy-le-sec 1
Nutley 1
Padova 1
Palermo 1
Piombino 1
Pomezia 1
Rho 1
Riva 1
San Pablo 1
Santiago 1
Southend 1
Terranova Da Síbari 1
Timisoara 1
Torino 1
Trumbull 1
Vienna 1
Westminster 1
Xian 1
Totale 1.447
Salva come PNG Salva come JPEG
Nome #
Prevenzione e terapia della meningosi leucemica 137
Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: An individual patient data meta-analysis 75
Randomized Phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: Health-related quality-of-life outcomes 74
BLOOD COAGULATION ABNORMALITIES IN CHRONIC MYELOID LEUKAEMIA. 69
High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC-GIMEMA AML-12 trial 66
High serum IL-2 levels are predictive of prolonged survival in multiple myeloma 59
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): Phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial) 55
null 55
null 55
Myelodysplastic syndromes in childhood: Description of seven cases 52
null 52
null 51
null 51
Therapy of childhood Acute Myelogenous Leukemia: an update of the AIEOP/LAM 8204 Study 50
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study 47
The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia 47
Intensified early therapy for childhood acute myeloid leukemia: pilot studies for the AIEOP cooperative group 43
null 43
null 43
Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia. 42
DHAP treatment: results of 18 patients with refractory or recurrent non Hodgkin's lymphoma. 42
null 40
I linfomi non-Hodgkin 39
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 39
Childhood myelodysplastic syndrome (MDS): report of 4 cases 39
CT brain scan findings in children with acute lymphoblastic leukemia (ALL) treated with 2 different CNS prophylaxis 36
Trattamento della leucemia linfoide acuta (LLA) in fase avanzata con l'associazione vincristina, ARA-C, methotrexate e prednisone 35
Effetti a distanza della radiochemioterapia sul sistema nervoso centrale 35
THERAPY-RELATED ACUTE MYELOMONOCYTIC LEUKEMIA FOLLOWING SUCCESSFUL TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA 32
Etoposide, ARA-C a dosi intermedie e Carboplatino (VAC): un nuovo programma di chemioterapia attivo nella leucemia mieloide acuta (LMA) refrattaria e nella crisi blastica di leucemia mieloide cronica (LMC-CB) 30
Second tumors in long-term survivors of childhood acute lymphoblastic leukemia (ALL) 29
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 29
Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group. 27
Trattamento del linfoma linfoblastico: risultati di due diversi schemi di polichemioterapia intensiva 27
Seconda neoplasia in 5 pazienti affetti da leucemia linfoide acuta fuori terapia 26
Anemia sideropenica del bambino 25
La chemioterapia nella leucemia mieloide acuta del bambino: stato attuale e prospettive future 25
I guariti da leucemia acuta: quanti e quale vita 25
Childhood Myelodysplastic Syndrome (MDS): report of 4 cases 25
Impiego delle IgG per via endovenosa ad alte dosi in preparazione ad interventi chirurgici nei bambini affetti da porpora trombocitopenica idiopatica 24
Recidiva oculare e meningea off-therapy in un bambino affetto da LLA 22
Therapy of acute nonlymphocytic leukemia in children. The AIEOP experience 21
Second malignancies in long-term survivors of childhood acute lymphocytic leukemia 20
Fattori prognostici cinetici nelle leucemie acute in trattamento con chemioterapia convenzionale e chemioterapia associata a citochine 20
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients 20
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 20
Mitoxantrone, etoposide and intermediate dose ARA-C (MEC) for the treatment of refractory acute myeloid leukemia 19
Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: Results of the randomized phase III EORTC-GIMEMA AML-19 Trial 19
Mitoxantrone, Etoposide and intermediate dose ARA-C (MEC) for the treatment of refractory acute myeloid leukemia 19
High dose ARA-C and Idarubicin for the treatment of advanced acute lymphocytic leukemia (ALL) 18
Terapia della leucemia acuta non linfoide del bambino 17
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT 17
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 16
La chemioterapia della leucemia mieloide acuta del bambino: stato attuale e prospettive future 14
Therapy of childhood acute myelogenous leukemia (AML): the AIEOP LAM 87 and LAM 87M studies 14
Linfoadenopatie in età pediatrica: esperienza di tre anni in un Centro di Ematologia 14
Linfomi non Hodgkin in età pediatrica 13
Idarubicn and high dose ARA-C in refractory ALL patients 12
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia 12
null 11
Therapy of acute nonlymphocytic leukemia in children. The AIEOP experience 10
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies 10
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 6
Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations 4
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial 3
IKZF1 (IKAROS) deletions represent a poor prognostic marker in BCR-ABL1 positive acute lymphoblastic leukaemia patients: a GIMEMA ALL WP report 1
Totale 2.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019131 0 0 0 0 0 0 0 0 0 0 72 59
2019/2020476 84 12 4 13 43 62 69 60 49 33 39 8
2020/2021105 17 11 2 7 4 9 4 14 8 7 17 5
2021/2022505 9 20 29 47 88 16 8 34 41 47 66 100
2022/2023534 137 49 10 65 45 77 21 29 69 3 22 7
2023/2024168 30 32 7 23 18 17 4 1 0 35 1 0
Totale 2.167